KMT5A and urinary bladder carcinoma: As recently demonstrated by Hamamoto and coworkers, SETD8 is overexpressed in different types of cancer tissues and cancer cell lines including bladder cancer, non-small cell and small cell lung carcinoma, chronic myelogenous leukemia, hepatocellular carcinoma and pancreatic cancer [28].